✦ LIBER ✦

Excellent response of chemotherapy-resistant B-cell-type chronic lymphocytic leukemia with meningeal involvement to rituximab

✍ Scribed by Naoko Watanabe; Takayuki Takahashi; Naoshi Sugimoto; Yasuhiro Tanaka; Masayuki Kurata; Akiko Matsushita; Akinori Maeda; Kenichi Nagai; Kohji Nasu

Book ID: 106284807
Publisher: Springer
Year: 2005
Tongue: English
Weight: 825 KB
Volume: 10
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-005-0496-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful treatment and re-treatment of

Successful treatment and re-treatment of resistant B-cell chronic lymphocytic leukemia with the monoclonal anti-CD 20 antibody rituximab

✍ M. Herold; A. Schulze; K. Härtwig; G. Anger 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 46 KB

2-Chlorodeoxyadenosine treatment in non-

2-Chlorodeoxyadenosine treatment in non-Hodgkin's Lymphoma and B-cell chronic lymphocytic leukemia resistant to conventional chemotherapy: results of a multicentric experience

✍ M. Brugiatelli; B. Holowiecka; A. Dmoszynska; O. Krieger; A. Planinc-Peraica; B. 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 165 KB

CD40 and B Chronic Lymphocytic Leukemia

CD40 and B Chronic Lymphocytic Leukemia Cell Response To Fludarabine: The Influence of NF-kB/Rel Transcription Factors On Chemotherapy-Induced Apoptosis

✍ Romano, Maria Fiammetta; Lamberti, Annalisa; Turco, Maria Caterina; Venuta, Salv 📂 Article 📅 2000 🏛 Informa plc 🌐 English ⚖ 707 KB

Overexpression of the chemokine receptor

Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1)

✍ Möhle, R; Failenschmid, C; Bautz, F; Kanz, L 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 124 KB

Valproic Acid, a Histone Deacetylase Inh

Valproic Acid, a Histone Deacetylase Inhibitor, Induces Apoptosis, Inhibits Proliferation, and Synergizes With Chemotherapy: The Rationale to Combine it for the Treatment of B-Cell Chronic Lymphocytic Leukemia

✍ Stamatopoulos, Basile; Lagneaux, L.; De Bruyn, C.; Mineur, P.; Willems, L. 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 46 KB

Early Results of a Phase II Study Adding

Early Results of a Phase II Study Adding Peri-Transplant Rituximab to Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients (PTS) with High-Risk Fludarabine-Refractory Chronic Lymphocytic Leukemia (Cll)

✍ M.L. Sorror; B. Storer; B.M. Sandmaier; T. Chauncey; B. Bruno; N.N.S. Andersen; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 93 KB